Insights to Cure Disease and Heal Healthcare
The only complete AI solution bringing to light unforeseen insights that promote better understanding of patient response, generate stronger evidence of clinical value and inform individualized care plans that maximize patient outcomes.
GNS Healthcare applies its groundbreaking, powerful artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.
We work with leading biopharma companies to accelerate and optimize drug discovery, development and commercialization. Our platform leverages both clinical trial data and real world data (RWD) to model patient response to treatment in silico. These insights enable biopharma to discover which subpopulations of patients respond, which do not and more importantly understand why, directly from the data and without bias. These models can also be used to conduct in silico clinical trials generating real world evidence of a drug’s value in the real world, both before and after launch.
We partner with innovative health plans to identify which members will respond to which drug and care management interventions at what point in time. Our platform provides a prescriptive approach allowing health plans to understand the effectiveness of specific interventions, member by member.
We work with progressive patient foundations to discover novel disease pathways and drug targets to accelerate the development of new therapeutics.
By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals to dramatically improve health outcomes and reduce the total cost of care. We have modeled over forty diseases in the areas of oncology, cardiovascular and metabolic, neurology, autoimmune and others.
We understand that in order to make precision medicine a reality, we need to discover and deliver novel insights that will cure disease and heal the healthcare system.
The REFS™ Platform
Our Reverse Engineering Forward Simulation (REFS) platform is the most powerful AI for identifying patient therapeutic response.
Speed to discovery
Our platform works by reconstructing complex diseases into computer models which allows users to simulate real world scenarios that take the guesswork out of critical decisions and increase the speed to discovery from years to months.
Transparency of results
By employing causal machine learning, our models not only deliver novel insights, they identify the underlying cause and effect relationships, crucial to understanding and treating the root cause of disease progression and patient response.
Unlimited data volume and variety
We transform and integrate millions of data points of all types – EMR, genetic, proteomic, genomic, claims, consumer, laboratory, prescription, mobile health, sociodemographic and more – revealing unforeseen relationships in a dynamic platform that continues to grow smarter over time.
Healthcare’s Most Powerful AI Solution
Understand the power of causal machine learning, why it’s different than other AI solutions and why it’s critical to transform biomedicine and healthcare. Check out video below to learn more.
GNS By The Numbers
We’re all about data points, numbers and evidence.
Complex Models Built
Data Points Modeled
Years Applying AI to Healthcare
Peer Reviewed Journal Articles & Posters
Why Is It So Hard to Define Value in Healthcare?
by email@example.com (GNS Healthcare) on August 8, 2019 at 1:14 pm
One of the more discussed topics in healthcare over the past decade has been the transition to a value-based system. No doubt it's a worthy goal, […]
Moving the Needle with Real World Data: How Oncology is Leading the Way
by firstname.lastname@example.org (GNS Healthcare) on August 1, 2019 at 2:12 pm
The thought of gathering massive amounts of data, from claims to EHR to molecular and making it easily accessible for drug development research once […]
Future of Pharma: Building the Right Environment for AI Success
by email@example.com (GNS Healthcare) on July 25, 2019 at 2:17 pm
What does the future of pharma look like through the eyes of a technologist’s background? We were fortunate enough to find out at last month at […]
News & Events
Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. –...read more
On November 12 GNS Healthcare scientists were joined by Dr. Alan Venook of UCLA and the Alliance for Clinical Trials in Oncology to discuss understanding what drugs work for whom in the context of colorectal cancer. To view the webinar recording or download the...read more
Forbes contributor Bruce Japsen notes that the Cigna investment "fits the effort by health insurance companies to use claims data and related patient health information to better target illness and provide more cost-effective and high quality patient care. These...read more
Understanding the AI Landscape
Check out our executive guide on understanding the AI landscape.
Improving The Probability of Success: New Tools in Drug Development
How robust data and powerful AI is changing the way drugs are developed.